Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Options -- Ignore unavailable to you. Want to Upgrade?

To: Poet who wrote (3038)	2/16/2000 11:48:00 AM
From: garyx	Read Replies (2) \| Respond to of 8096

Hey poet, thanx for the cyber-affection, it is appreciated! Umm, re: HGSI (not hsgi, btw) I am not a holder. I hold CRA, which I like better since it seems to be positioning itself as the necessary middleman for all genomics-based work in the next century. HGSI probly will do just as well -- they certainly are picking their targets well -- but my other stocks are doing so well I can't sell anything. CCR5 is just one of the "turnkeys" that is critical in the hiv infects cell cycle. If I recall correctly, people who have mutations preventing them from showing CCR5 are immune to HIV. So that news is good, 'cept it will take 10 years to do anything ith. Gene stuff is so complicated, I would rather bet my money on someone like CRA who I see as selling information -- a kind of genomics pick and shovel play, like Affymetrix and their gene chip. :D G-Nice